NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
4.170
-0.260 (-5.87%)
At close: Dec 5, 2025, 4:00 PM EST
4.173
+0.003 (0.07%)
After-hours: Dec 5, 2025, 7:59 PM EST
NuCana Market Cap
NuCana has a market cap or net worth of $17.36 million as of December 5, 2025. Its market cap has increased by 478.50% in one year.
Market Cap
17.36M
Enterprise Value
-16.40M
1-Year Change
478.50%
Ranking
Category
Stock Price
$4.17
Market Cap Chart
Since September 28, 2017, NuCana's market cap has decreased from $513.70M to $17.36M, a decrease of -96.62%. That is a compound annual growth rate of -33.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 17.40M | 270.21% |
| Dec 31, 2024 | 4.70M | -69.87% |
| Dec 29, 2023 | 15.60M | -54.65% |
| Dec 30, 2022 | 34.40M | -72.30% |
| Dec 31, 2021 | 124.20M | -21.19% |
| Dec 31, 2020 | 157.60M | -19.84% |
| Dec 31, 2019 | 196.60M | -57.38% |
| Dec 31, 2018 | 461.30M | 43.44% |
| Dec 29, 2017 | 321.60M | -37.40% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 902.32B |
| Johnson & Johnson | 486.99B |
| AbbVie | 401.16B |
| UnitedHealth Group | 299.77B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 248.18B |
| Abbott Laboratories | 217.95B |